Solicitation released July 12, 2019 for IQVIA Technology Solutions and Research Services – Solicitation Number: 75D301-19-Q-69782.
“Under the authority of FAR 6.302-1, only one responsible source and no other supplies or services will satisfy agency requirements, the Centers for Disease Control and Prevention (CDC) contemplates entering into a negotiated, Firm-fixed price type contract with IMS Government Solutions of Fairfax, VA.
The Centers for Disease Control and Prevention (CDC), Office of Public Health Scientific Services (OPHSS), Center for Surveillance, Epidemiology and Laboratory Services (CSELS), Epidemiology and Laboratory Services, Division of Health Informatics and Surveillance, needs to obtain access to data on IQVIA’s SMART platform or customized data extracts, and reports. IQVIA is The Human Data Science CompanyTM, focused on using data and science to help healthcare clients find better solutions for their patients. Formed through the merger of IMS Health and Quintiles, IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward. This project is focused on acquiring licenses for pharmacy data and seats on SMART platform that will be used by researchers to query the data, develop studies and conduct analysis with the ultimate goal to gain a better understanding of these data and their use for public health programs and surveillance.
The anticipated period of performance is 9/1/2019 – 8/31/2022, base and options included. This acquisition will be conducted in accordance with FAR Part 12, Acquisition of Commercial Items, in conjunction with FAR Part 15.
IQVIA’s client solutions are powered by the IQVIA CORETM. The CORE enables IQVIA to provide customized solutions for clients leveraging the world’s largest curated healthcare information source, advanced analytics, leading technologies and extensive industry knowledge across diseases, geographies and scientific methods. To the best of our knowledge, IMS Government Solutions (IQVIA) is the only source for this product; it is also the only company that meets the requirements to provide near real time, current data of a population size that lends itself credible to research studies. In addition, it is the only provider that gives researcher (users) access to the data so they can manipulate as needed to build their phenotypes into cohort studies…”
